Real-Time Image-Guided Cryobiopsy of a Right
Lower Lobe (RLL) Cavitary Lesion

Case Details
Lesion Characteristics
Lesion Size (diameter): 30 mm
Lesion Location: Right Lower Lobe (RLL)
Bronchus Sign: Yes
Visible on Fluoro: Yes
Case Information
Final Pathology Report: Squamous Cell Carcinoma
Background
A 74-year-old female patient presented with a growing cavernous mass in the apical
segment of her right lower lobe. The patient exhibited mild dyspnea and productive
coughing and had a significant smoking history of 75 pack-years. CT imaging revealed
a lesion with a maximal wall thickness of 0.8 cm and a positive bronchus sign. Given
the lesion’s challenging location—adjacent to the rib and mediastinum—a CT-guided
biopsy was deemed high-risk. A navigational bronchoscopy using the LungVision®
(Body Vision Medical) platform was selected for tissue sampling.
The Procedure
The bronchoscopy was performed under general anesthesia using the Artis Zee 2D
C-arm (Siemens) and an H-190 bronchoscope (Olympus). Augmented fluoroscopy
provided by LungVision facilitated precise localization of the lesion, although initial
attempts to obtain samples using standard forceps and needles were unsuccessful
due to acute angulation. A 1.1 mm cryoprobe (Erbe Medical) was successfully employed, and “tool-in-lesion” confirmation with LungVision validated accurate
positioning. Histopathology confirmed squamous cell carcinoma. The patient was
subsequently treated with chemotherapy and radiotherapy.
Coronal | Axial | Sagittal | |
Pre-operative CT | ![]() | ![]() | ![]() |
LungVision AI Tomo intraoperative image | ![]() | ![]() | ![]() |
Fig 2. Paired images showing pre-operative CT scan of Right Lower Lobe (RLL) pulmonary lesion in coronal, axial, and sagittal planes and corresponding AI Tomo 3D tomographic images captured intraoperatively using LungVision prior to introduction of bronchoscope.

Conclusion
This case demonstrates the utility of augmented fluoroscopy in navigating complex lung anatomy. The real time augmented fluoroscopy and imaging helped recognize the limitations of the standard tools and led to the use of the cryoprobe. The LungVision platform supports the use of most available biopsy tools, thus facilitating such multimodal sampling. In addition to the clinical benefits of enhancing diagnostic yield, Å we must also address the financial considerations when incorporating new technologies; Germany's hospital reimbursement system is based on the Diagnose-Related Group (DRG) system which pays a flat fee for each of these procedures. Technologies that require proprietary tools add to the per-procedure cost, particularly for a procedure such as diagnostic bronchoscopy for which the reimbursement rate is low, increasing the financial burden on the hospital. Thus, the value of being able to use standard tools and bronchoscopes with the LungVision platform cannot be overstated.
References
1. Verhoeven RLJ, Vos S, van der Heijden EHFM. Multi-modal tissue sampling in cone beam CT-guided navigation
bronchoscopy: comparative accuracy of different sampling tools and rapid on-site evaluation of cytopathology.
J Thorac Dis. 2021 Jul;13(7):4396-4406. doi: 10.21037/jtd-21-518.PMID: 34422366; PMCID: PMC8339773.
About Dr. Björn Schwick Dr. med. José Miguel Sodi Luna

Dr. Björn Schwick
Chief Physician
Department of Pulmonology
Luisenhospital Aachen
Aachen, Germany

Dr. med. José Miguel Sodi Luna
Senior Physician
Department of Pulmonology
Luisenhospital Aachen
Aachen, Germany